About Newcells Biotech
Newcells Biotech is a company based in Newcastle Upon Tyne (United Kingdom) founded in 2014.. Newcells Biotech has raised $14.43 million across 9 funding rounds from investors including Mercia, European Union and NVM Private Equity. Newcells Biotech offers products and services including Retinal Organoids, Kidney Nephron Models, and Lung Airway Models. Newcells Biotech operates in a competitive market with competitors including InSphero, Pandorum, Vivodyne, Adapsyn and Cellesce, among others.
- Headquarter Newcastle Upon Tyne, United Kingdom
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Newcells Biotech Limited
- Date of Incorporation 15 Jan, 2015
- Jurisdiction NEWCASTLE UPON TYNE, TYNE AND WEAR, UNITED KINGDOM
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$14.43 M (USD)
in 9 rounds
-
Latest Funding Round
$1.47 M (USD), Series B
Dec 05, 2024
-
Investors
Mercia
& 5 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Newcells Biotech
Newcells Biotech offers a comprehensive portfolio of products and services, including Retinal Organoids, Kidney Nephron Models, and Lung Airway Models. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Models for retinopathies and safety studies in drug testing
Used for toxicity and drug interaction assessments
Facilitates fibrotic disease and compound efficacy studies
Unlock access to complete
Unlock access to complete
Funding Insights of Newcells Biotech
Newcells Biotech has successfully raised a total of $14.43M across 9 strategic funding rounds. The most recent funding activity was a Series B round of $1.47 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Series B — $1.5M
- First Round First Round
- Investors Count 6
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2024 | Amount | Series B - Newcells Biotech | Valuation |
investors |
|
| Feb, 2024 | Amount | Series B - Newcells Biotech | Valuation | North East Fund | |
| Feb, 2021 | Amount | Series B - Newcells Biotech | Valuation | Mercia , Northstar Ventures |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Newcells Biotech
Newcells Biotech has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Mercia, European Union and NVM Private Equity. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are made in UK companies across diverse sectors.
|
Founded Year | Domain | Location | |
|
Investment finance is provided to small and medium-sized enterprises.
|
Founded Year | Domain | Location | |
|
Regional investment funds are managed by North East Finance.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Newcells Biotech
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Newcells Biotech
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Newcells Biotech Comparisons
Competitors of Newcells Biotech
Newcells Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as InSphero, Pandorum, Vivodyne, Adapsyn and Cellesce, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cell-based assays and 3D microtissues for drug screening are developed.
|
|
| domain | founded_year | HQ Location |
Regenerative medicine and 3D tissues are developed for therapeutic uses.
|
|
| domain | founded_year | HQ Location |
Developer of AI-based platform for lab-grown human tissues
|
|
| domain | founded_year | HQ Location |
Provider of computational tools for bacterial metabolomic and genomic data analysis
|
|
| domain | founded_year | HQ Location |
Scalable processes for organoid expansion are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Newcells Biotech
Frequently Asked Questions about Newcells Biotech
When was Newcells Biotech founded?
Newcells Biotech was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Where is Newcells Biotech located?
Newcells Biotech is headquartered in Newcastle Upon Tyne, United Kingdom.
Is Newcells Biotech a funded company?
Newcells Biotech is a funded company, having raised a total of $14.43M across 9 funding rounds to date. The company's 1st funding round was a Series B of $7.37M, raised on Sep 02, 2015.
What does Newcells Biotech do?
Newcells Biotech was founded in 2014 in Newcastle Upon Tyne, United Kingdom, within the biotechnology sector. Induced pluripotent stem cell-derived organoid models are created for research applications. Off-the-shelf products, such as neural progenitor cells and cardiomyocytes, are offered alongside custom reprogramming and differentiation services. These are provided to biopharmaceutical companies and research institutions to support drug development and scientific studies.
Who are the top competitors of Newcells Biotech?
Newcells Biotech's top competitors include InSphero, Vivodyne and Parallel Bio.
What products or services does Newcells Biotech offer?
Newcells Biotech offers Retinal Organoids, Kidney Nephron Models, and Lung Airway Models.
Who are Newcells Biotech's investors?
Newcells Biotech has 6 investors. Key investors include Mercia, European Union, NVM Private Equity, Northstar Ventures, and North East Fund.